We are live on ! Find out more
JNJ icon

Johnson & Johnson

2,584 hedge funds and large institutions have $251B invested in Johnson & Johnson in 2018 Q3 according to their latest regulatory filings, with 84 funds opening new positions, 1,107 increasing their positions, 1,110 reducing their positions, and 69 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more first-time investments, than exits

New positions opened: 84 | Existing positions closed: 69

18% more funds holding in top 10

Funds holding in top 10: 553651 (+98)

14% more capital invested

Capital invested by funds: $219B → $251B (+$31.6B)

0.08% more ownership

Funds ownership: 67.58%67.66% (+0.08%)

0% less repeat investments, than reductions

Existing positions increased: 1,107 | Existing positions reduced: 1,110

0% less funds holding

Funds holding: 2,5932,584 (-9)

26% less call options, than puts

Call options by funds: $1.49B | Put options by funds: $2.02B

Holders
2,584
Holders Change
-9
Holders Change %
-0.35%
% of All Funds
59.06%
Holding in Top 10
651
Holding in Top 10 Change
+98
Holding in Top 10 Change %
+17.72%
% of All Funds
14.88%
New
84
Increased
1,107
Reduced
1,110
Closed
69
Calls
$1.49B
Puts
$2.02B
Net Calls
-$525M
Net Calls Change
-$83.1M
Name Holding Trade Value Shares
Change
Change in
Stake
PCMK
901
Paragon Capital Management (Kansas)
Kansas
$8.87M +$8.19M +61,635 +2,430%
VW
902
Vantage Wealth
California
$8.86M -$108K -816 -1%
HFS
903
Haverford Financial Services
Pennsylvania
$8.85M -$70.7K -532 -0.8%
IIC
904
Ironwood Investment Counsel
Arizona
$8.84M +$53K +399 +0.6%
GT
905
Greenleaf Trust
Michigan
$8.84M +$418K +3,142 +5%
WSCM
906
Wellington Shields Capital Management
New York
$8.82M +$1.8M +13,531 +27%
QT
907
Quantbot Technologies
New York
$8.79M +$5.76M +43,353 +214%
CA
908
Cetera Advisors
Colorado
$8.79M +$399K +3,001 +5%
BFA
909
Bragg Financial Advisors
North Carolina
$8.79M +$95.4K +718 +1%
BCM
910
Beddow Capital Management
Wyoming
$8.77M -$535K -4,025 -6%
OPCM
911
Osborne Partners Capital Management
California
$8.75M -$137K -1,031 -2%
PP
912
Prospector Partners
Connecticut
$8.75M +$133K +1,000 +2%
GP
913
Greenline Partners
New York
$8.72M -$47.2K -355 -0.6%
MCM
914
Monarch Capital Management
Indiana
$8.7M -$141K -1,062 -2%
LSA
915
L & S Advisors
California
$8.69M +$6.27M +47,162 +300%
GCA
916
Greenwood Capital Associates
South Carolina
$8.67M -$31.9K -240 -0.4%
ASN
917
Advisory Services Network
Georgia
$8.67M +$59.7K +449 +0.7%
IIM
918
Ipswich Investment Management
Massachusetts
$8.64M +$189K +1,425 +2%
MRCM
919
M&R Capital Management
New Jersey
$8.62M -$58.5K -440 -0.7%
JCM
920
Jacobi Capital Management
Pennsylvania
$8.58M +$41.1K +309 +0.5%
HC
921
Hendley & Co
Ohio
$8.58M -$91.3K -687 -1%
CC
922
ClearArc Capital
Ohio
$8.56M +$78.9K +594 +1%
OAM
923
Oxford Asset Management
United Kingdom
$8.55M +$7.35M +55,297 +838%
CAM
924
Cypress Asset Management
Texas
$8.54M -$461K -3,470 -5%
HCM
925
Hutner Capital Management
Vermont
$8.52M -$16.7K -126 -0.2%

JNJ Hedge Fund Activity: Q3 2018 in Review

2,584 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q3 2018, worth a combined $251B — up 14% from $219B a quarter earlier.

Buyers outnumbered sellers: 84 funds opened new JNJ positions and 69 closed out — a net gain of 15 holders — while 1,107 added to existing stakes and 1,110 trimmed.

The largest buyer was Capital International Investors, adding an estimated $2.49B. The largest seller was Capital World Investors, cutting an estimated $2.21B.

  • 2,584 institutional investors held Johnson & Johnson (JNJ) as of Q3 2018, down from 2,593 in Q2 2018.
  • Funds reported $251B of Johnson & Johnson stock for Q3 2018, up 14% quarter-over-quarter.
  • 84 funds opened new Johnson & Johnson positions in Q3 2018 and 69 closed out, a net change of +15 holders.
  • The largest Johnson & Johnson buyer in Q3 2018 was Capital International Investors, an estimated $2.49B added.
  • The largest Johnson & Johnson seller in Q3 2018 was Capital World Investors, an estimated $2.21B sold.

Based on aggregated 13F filings for Q3 2018.